Fig. 1: Colesevelam therapy effects on lenalidomide-associated diarrhea and lenalidomide pharmacokinetics.
From: Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
Response to colesevelam therapy by patient and number of weeks of treatment (A). Dose normalized lenalidomide pharmacokinetics before and after starting colesevelam (B).
